Lysogene

Paris, France Specialty Founded 2009 51-200 employees

French clinical-stage gene therapy company and CRO specializing in CNS gene therapy development, providing clinical trial management for rare neurological diseases.

Services

CLINICAL

Phase I Clinical Trials Phase II Clinical Trials

MANUFACTURING

Cell & Gene Therapy Manufacturing

REGULATORY

Regulatory Strategy

Therapeutic Areas

CNS Rare Disease Cell & Gene Therapy

Contact

Locations

Paris, France

Certifications

GCP Compliant GMP

Regulatory Experience

EMAFDA